About
Non-invasive cancer therapies
Areas of Focus
Categories
Small Molecule PharmaceuticalDrug Delivery & FormulationBiotech
Team (14)
Alan Chiang
Alan Chiang, MD, PhD, MBA, FICS
NeOnc Technologies
team_member
Alexandra M
Alexandra M. Miller, MD, PhD, NYU Langone Health
NeOnc Technologies
team_member
Amir F
Amir F. Heshmatpour
NeOnc Technologies
team_member
Axel H
Axel H. Schönthal, PhD
NeOnc Technologies
team_member
Bader Al Monawer
Bader Al Monawer
NeOnc Technologies
team_member
David M
David M. Ashley, MBBS (Hons), FRACP, PhD, Duke University
NeOnc Technologies
team_member
Clinical Trials (4)
View allTotal Trials
4
As Lead Sponsor
4
As Collaborator
0
Total Enrollment
228
By Phase
PHASE1: 1PHASE1/PHASE2: 2PHASE2: 1
By Status
RECRUITING: 3NOT_YET_RECRUITING: 1
Clinical Trials Pipeline4 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT06357377Lead Sponsor
A Study of the Safety, Dosing, and Delivery of NEO100 in Patients with Pediatric Brain Tumors
PHASE1Not yet recruiting
15 participants
Started: Dec 31, 2024 · Completed: Oct 31, 2025
NCT06047379Lead Sponsor
Safety and Efficacy of NEO212 in Patients with Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
PHASE1/PHASE2Recruiting
134 participants
Started: Nov 1, 2023 · Completed: Aug 31, 2026
NCT05023018Lead Sponsor
NEO100 and High-Grade Meningioma
PHASE2Recruiting
30 participants
Started: Jul 1, 2022 · Completed: Sep 30, 2026
NCT02704858Lead Sponsor
Safety and Efficacy Study in Recurrent or Progressive Grade III or IV IDH1 Mutated Glioma
PHASE1/PHASE2Recruiting
49 participants
Started: Aug 1, 2017 · Completed: Dec 31, 2025
Locations (1)
Headquarters
Sacramento, CA, United States
Map
Loading map...